Science Explorer Back to mapMap
Discussion
Company · Livermore · United States

Acumen Pharmaceuticals (United States)

acumenpharm.comROR OpenAlex
Research works
34
▲ 1404% vs 2018-21
Citations
2.1k
61.2 per fractional work
Top-10% rate
10.4%
all institutions 10.0%
Open access
67%
world 40%
International
17%
world 18%
Acumen Pharmaceuticals (United States)

Not ranked overall: Acumen Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Acumen Pharmaceuticals (United States) work in?

In all years, 63% of research at Acumen Pharmaceuticals (United States) is in Health Sciences, 20% in Life Sciences. Its largest fields are Medicine (53%), Biochemistry, Genetics and Molecular Biology (13%), Computer Science (9%). It does 2.2× the world's share of Health Sciences.

Health Sciences: 21 fractional works · 62.6% of its workMedicine: 18 fractional works · 53.4% of its workPhysiology: 8 fractional works · 24.9% of its workPharmacology: 3 fractional works · 8.6% of its workPsychiatry and Mental health: 2 fractional works · 6.3% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 3.6% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 2.1% of its workComplementary and alternative medicine: 1 fractional works · 1.9% of its workNeurology: 0 fractional works · 1.5% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.4% of its workSurgery: 0 fractional works · 0.7% of its workEpidemiology: 0 fractional works · 0.6% of its workHematology: 0 fractional works · 0.4% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.4% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workOncology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 3 fractional works · 9.2% of its workGeneral Health Professions: 2 fractional works · 5.1% of its workMedical Laboratory Technology: 1 fractional works · 2.9% of its workHealth Information Management: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workLife Sciences: 7 fractional works · 20.3% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 12.8% of its workMolecular Biology: 3 fractional works · 9.2% of its workBiophysics: 1 fractional works · 2.9% of its workCell Biology: 0 fractional works · 0.6% of its workNeuroscience: 2 fractional works · 5.2% of its workCellular and Molecular Neuroscience: 1 fractional works · 1.9% of its workNeurology: 1 fractional works · 1.8% of its workBiological Psychiatry: 0 fractional works · 1.2% of its workCognitive Neuroscience: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workAgricultural and Biological Sciences: 1 fractional works · 2.2% of its workPlant Science: 1 fractional works · 2.2% of its workImmunology and Microbiology: 0 fractional works · 0.0% of its workPhysical Sciences: 5 fractional works · 13.7% of its workComputer Science: 3 fractional works · 9.4% of its workComputational Theory and Mathematics: 3 fractional works · 9.0% of its workSmaller subfields together: 0 fractional works · 0.4% of its workEngineering: 1 fractional works · 2.0% of its workBiomedical Engineering: 0 fractional works · 1.0% of its workMedia Technology: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.0% of its workMathematics: 0 fractional works · 1.2% of its workStatistics and Probability: 0 fractional works · 1.2% of its workChemistry: 0 fractional works · 1.0% of its workOrganic Chemistry: 0 fractional works · 1.0% of its workEnvironmental Science: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 3.4% of its workEconomics, Econometrics and Finance: 1 fractional works · 2.1% of its workEconomics and Econometrics: 1 fractional works · 2.1% of its workBusiness, Management and Accounting: 0 fractional works · 1.0% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 1.0% of its workSocial Sciences: 0 fractional works · 0.2% of its workPsychology: 0 fractional works · 0.1% of its workALL ITS WORKAcumenPharmaceuticals…34fractional works, all years
Life Sciences20%Physical Sciences14%Health Sciences63%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine1853.4%
    2. Health Professions39.2%
    1. Biochemistry, Genetics and Molecular Biology412.8%
    2. Neuroscience25.2%
    3. Agricultural and Biological Sciences12.2%
    4. Immunology and Microbiology00.0%
    1. Computer Science39.4%
    2. Engineering12.0%
    3. Mathematics01.2%
    4. Chemistry01.0%
    5. Environmental Science00.1%
    1. Economics, Econometrics and Finance12.1%
    2. Business, Management and Accounting01.0%
    3. Social Sciences00.2%
    4. Psychology00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.87× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.62× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 0.02× its world share, 0 worksImmunology and Micro…Neuroscience: 1.46× its world share, 0 worksNeuroscienceComputer Science: 0.65× its world share, 1 worksComputer ScienceEngineering: 0.12× its world share, 0 worksEngineeringEnvironmental Science: 0.04× its world share, 0 worksEnvironmental ScienceMathematics: 1.96× its world share, 0 worksMathematicsHealth Professions: 6.48× its world share, 3 worksHealth ProfessionsMedicine: 3.01× its world share, 10 worksMedicineBusiness, Management and Accounting: 0.57× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.87× its world share, 1 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Health Professions, 6.5×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Health Professions6.48×3 works
  2. Medicine3.01×10 works
  3. Mathematics1.96×0 works
  4. Economics, Econometrics and Finance1.87×1 works
  5. Neuroscience1.46×0 works
  6. Agricultural and Biological Sciences0.87×1 works
  7. Computer Science0.65×1 works
  8. Biochemistry, Genetics and Molecular Biology0.62×1 works
  9. Business, Management and Accounting0.57×0 works
  10. Engineering0.12×0 works
  11. Environmental Science0.04×0 works
  12. Immunology and Microbiology0.02×0 works

Who are the top researchers at Acumen Pharmaceuticals (United States)?

Ranked on the quality score, Jasna Jerecı̀ć lead among researchers whose main affiliation is Acumen Pharmaceuticals (United States).

  1. 1 Jasna Jerecı̀ć United States · #824,326 worldwide 1.3k citations · 24 works
All ranked researchers at Acumen Pharmaceuticals (United States)

What are the most cited papers from Acumen Pharmaceuticals (United States)?

The most cited paper from Acumen Pharmaceuticals (United States) is "Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup" (Clifford R. Jack, Jeffrey Scott Andrews, Thomas G. Beach et al., 2024), with 2,670 citations. Next come "Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis" (1,244) and "Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss" (1,069).

Most cited papers
#PaperReleasedCitations
1 Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup Clifford R. Jack, Jeffrey Scott Andrews, Thomas G. Beach et al. · Alzheimer s & Dementia Open access 27 Jun 2024 2,670
2 Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis Yasser Iturria‐Medina et al. · Nature Communications Open access316 authors 21 Jun 2016 1,244
3 Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss Yuesong Gong, Lei Chang, Kirsten L. Viola et al. · Proceedings of the National Academy of Sciences Open access 18 Aug 2003 1,069
4 Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers Pascale N. Lacor, Maria C. F. Buniel, Lei Chang et al. · Journal of Neuroscience Open access 10 Nov 2004 964
5 Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference Alexandra L. Young et al. · Nature Communications Open access380 authors 9 Oct 2018 613
All 89 most cited papers, with filters and sorting

Which keywords describe research at Acumen Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Neuroinflammation, Oxidative Stress, Neurodegeneration, Amyloid Hypothesis, Tau Pathology, Alzheimer's Disease, Machine Learning and Pharmacokinetics.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 35 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 35 words, with their numbers
  1. Neuroinflammation8▲ 87×4 topics
  2. Oxidative Stress8▲ 13×7 topics
  3. Neurodegeneration8▲ 72×6 topics
  4. Amyloid Hypothesis7▲ 391×1 topic
  5. Tau Pathology7▲ 391×1 topic
  6. Alzheimer's Disease5▲ 58×6 topics
  7. Machine Learning5▲ 6.6×6 topics
  8. Pharmacokinetics3▲ 36×2 topics
  9. Molecular Docking3▲ 63×1 topic
  10. Virtual Screening3▲ 128×1 topic
  11. Neurodegenerative Diseases3▲ 38×4 topics
  12. Biomarkers2▲ 12×5 topics
  13. Pharmacology2▲ 22×2 topics
  14. Acetylcholinesterase2▲ 251×1 topic
  15. Cholinesterase Inhibitors2▲ 251×1 topic
  16. Dementia2▲ 96×2 topics
  17. Aging2▲ 12×2 topics
  18. Neuroimaging2▲ 22×3 topics
  19. Cognitive Decline2▲ 55×1 topic
  20. Mild Cognitive Impairment2▲ 95×1 topic
  21. Patient Engagement1▲ 46×1 topic
  22. Public Involvement1▲ 192×1 topic
  23. Antioxidant1▲ 5.8×4 topics
  24. Healthcare1▲ 5.5×3 topics
  25. Neuroprotective1▲ 27×3 topics
  26. Anti-inflammatory1▲ 10×2 topics
  27. Clinical Trials1▲ 4.7×2 topics
  28. Ethnopharmacology1▲ 48×2 topics
  29. Image Processing1▲ 9.2×2 topics
  30. Maintenance1▲ 43×1 topic
  31. Management1▲ 3.8×3 topics
  32. Medical Equipment1▲ 116×1 topic
  33. Microscopy1▲ 49×2 topics
  34. Preanalytical Variables1▲ 190×1 topic
  35. Reference Intervals1▲ 190×1 topic

Which research topics does Acumen Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Mental Health and Patient Involvement and Cholinesterase and Neurodegenerative Diseases.

Alzheimer's disease rese…3Alzheimer's disease research and treatments: 3 fractional worksDementia and Cognitive Impairment Research: 2 fractional worksMental Health and Patient Involvement: 1 fractional worksCholinesterase and Neurodegenerative Diseases: 1 fractional worksQuality and Safety in Healthcare: 1 fractional worksClinical Laboratory Prac…1Clinical Laboratory Practices and Quality Control: 1 fractional worksComputational Drug Discovery Methods: 1 fractional worksEthics in Clinical Research: 1 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 1 fractional worksPhytochemistry and Biological Activities: 0 fractional works
PhysiologyPsychiatry and Mental healthGeneral Health ProfessionsPharmacology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Alzheimer's disease research and treatments Physiology 3 works
  2. 2 Dementia and Cognitive Impairment Research Psychiatry and Mental health 2 works
  3. 3 Mental Health and Patient Involvement General Health Professions 1 works
  4. 4 Cholinesterase and Neurodegenerative Diseases Pharmacology 1 works
  5. 5 Quality and Safety in Healthcare Medical Laboratory Technology 1 works
  6. 6 Clinical Laboratory Practices and Quality Control Physiology 1 works
  7. 7 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
  8. 8 Ethics in Clinical Research Public Health, Environmental and Occupational Health 1 works
  9. 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  10. 10 Phytochemistry and Biological Activities Plant Science 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available67.2%not open32.8%

World: 40% of research is openly available.

with international co-authors17.0%domestic only83.0%

World: 18% is written across borders.

How has Acumen Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 1404% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Acumen Pharmaceuticals (United States) as a percentage of every work published that year, 0.00011% in 2024.

still counting0.000050%0.00010%0.00015%Acumen Pharmaceuticals (United States)0.000090% in 202520102020

Fractional works of Acumen Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Livermore

All research institutions in Livermore

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Acumen Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.